| T-Stage: | |
| · T1 | 32 (8.2%) |
| · T2 | 216 (55.6%) |
| · T3 | 73 (18.8%) |
| · T4 | 44 (11.3%) |
| · Tx | 23 (6.1%) |
| Nodal-Stage | |
| · N0 | 116 (29.9%) |
| · N1 | 127 (32.7%) |
| · N2 | 62 (15.9%) |
| · N3 | 65 (16.7%) |
| · Nx | 18 (4.8%) |
| Hormone Receptor Status: | |
| · ER PR Positive | 201 (51.8%) |
| · ER Positive PR Negative | 49 (12.6%) |
| · ER Negative PR Positive | 11 (2.9%) |
| · ER PR Negative | 127 (32.7%) |
| · Triple Negative | 28 (7.2%) |
| HER2-neu expression: | |
| · 0/+1 | 110 (28.4%) |
| · +2 | 20 (4.9%) |
| · +3 | 38 (9.8%) |
| · Unknown | 221 (56.9%) |